INT-747

obeticholic acid · Intercept Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INT-747, covering 2011-07-07 to 2012-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC) [Phase 2]